Review ArticleReview

Targeting PP2A for cancer therapeutic modulation

Halle Ronk, Jared S. Rosenblum, Timothy Kung and Zhengping Zhuang
Cancer Biology & Medicine October 2022, 19 (10) 1428-1439; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0330

Article Information

vol. 19 no. 10 1428-1439
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2022.0330
Published By 
Cancer Biology & Medicine
History 
  • Received June 15, 2022
  • Accepted August 26, 2022
  • Published online November 3, 2022.
Copyright & Usage 
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Halle Ronk1,
  2. Jared S. Rosenblum1,
  3. Timothy Kung1 and
  4. Zhengping Zhuang1⇑
  1. 1Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
  1. Correspondence to: Zhengping Zhuang, E-mail: zhengping.zhuang{at}nih.gov
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords